COL11A1 and ovarian cancer: COL11A1 promotes the phosphorylation of SP1, which in turn promotes the transcriptional activation of IKKβ, leading to the increased expression of Twist1 induced by NF-κB, thus causing drug resistance in ovarian cancer cells (32).